Inhibitory effect of E3330, a novel quinone derivative able to suppress tumor necrosis factor-α generation, on activation of nuclear factor-κB

Molecular Pharmacology

Volumn 49, Issue 5, 1996, Pages 860-873

  Goto, Masaki ^a   Yamada, Koji ^a   Katayama, Kou Ichi ^a   Tanaka, Isao ^a  

^a EISAI CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2,3 DIMETHOXY 6 METHYL 1,4 BENZOQUINON 5 YL) 2 NONYL 2 PROPENOIC ACID; ALKALINE PHOSPHATASE PLACENTA ISOENZYME; E 3330; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGONUCLEOTIDE; QUINONE DERIVATIVE; SUPEROXIDE; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DNA PROBE; GENE ACTIVATION; GENE REPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSACTIVATION;

ALKALINE PHOSPHATASE; ANIMALS; BASE SEQUENCE; BENZOQUINONES; CELL LINE; DNA PRIMERS; GENE EXPRESSION; HUMANS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MONOCYTES; NF-KAPPA B; PHOSPHORYLATION; PLACENTA; PROMOTER REGIONS (GENETICS); PROPIONIC ACIDS; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; SUPEROXIDES; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029872796     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Gordon, S., I. Fraser, D. Nath, D. Hughes, and S. Clarke. Macrophages in tissues and in vitro. Curr. Opin. Immunol. 4:25-32 (1992).
2. Beutler, B., and A. Cerami. Cachectin and tumor necrosis factor as two sides of same biological coin. Nature (Lond.) 320:548-558 (1986).
3. Duh, E., W. J. Maury, T. M. Folks, A. S. Fauci, and A. B. Rabson. Tumor necrosis factor a activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86:5974-5978 (1989).
4. Muto, Y., K. T. Nouri-Aria, A. Meager, G. J. M. Alexander, A. L. W. F. Eddleston, and R. Williams. Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet. 2:72-74 (1988).
5. McClain, C. J., and D. A. Cohen. Increased tumor necrosis factor production by human monocytes in alcoholic hepatitis. Hepatology 9:349-351 (1989).
6. Yoshikawa, K., S. Kakumu, M. Arao, Y. Tsutsumi, and M. Inoue. Tumor necrosis factor α production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology 10:769-773 (1989).
7. Miyamoto, K., J. Nagakawa, I. Hishinuma, K. Hirota, M. Yasuda, K. Katayama, and I. Yamatsu. Suppressive effects of E3330, a novel quinone derivative, on tumor necrosis factor-α generation from monocytes and macrophages. Agents Actions 37:297-304 (1992).
8. Nagakawa, J., I. Hishinuma, K. Miyamoto, K. Hirota, S. Abe, T. Yamanaka, K. Katayama, and I. Yamatsu. Protective effects of (2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4-benzoquinoyl)]-2-nonyl-2-propenoic acid on endotoxin-mediated hepatitis in mice. J. Pharmacol. Exp. Ther. 262:145-150 (1992).
9. Nagakawa, J., K. Hirota, I. Hishinuma, K. Miyamoto, J. Sonoda, T. Yamanaka, K. Katayama, and I. Yamatsu. Protective effect of E3330, a novel quinone derivative, in galactosamine-induced hepatitis in rats. J. Pharmacol. Exp. Ther. 264:496-500 (1993).
10. Economou, J. S., K. Rhoades, R. Essner, W. H. McBride, J. C. Gasson, and D. L. Morton. Genetic analysis of the human tumor necrosis factor α/cachectin promoter region in a macrophage cell line. J Exp. Med. 170:321-326 (1989).
11. Drouet, C., A. N. Shakhov, and C. V. Jongeneel. Enhancers and transcription factor controlling the inducibility of the tumor necrosis factor-α promoter in primary macrophages. J. Immunol. 147: 1694-1700 (1991).
12. Collart, M A., P. Baeuerle, and P. Vassalli. Regulation of tumor necrosis factor a transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell. Biol. 10:1498-1506 (1990).
13. Baeuerle, P. A., and T. Henkel. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-179 (1994).
14. Siebenlist, U., K. Brown, and G. Franzoso. NF-κB: a mediator of pathogen and stress responses, in Inducible Gene Expression (P. A. Baeuerle, ed.). Vol. 1. Birkhauser, Boston, 93-139 (1995).
15. Goto, M., K. Chiba, R. Hashida, and H. Shirota. A novel inhibitor of IL-1 generation, E5090: in vitro inhibitory effects on the generation of IL-1 by human monocytes. Agents Actions Suppl 32:225-229 (1991).
16. Millan, J. L. Molecular cloning and sequence analysis of human placental alkaline phosphatase. J. Biol. Chem. 261:3112-3115 (1986).
17. Berger, J., J. Hauber, R. Hauber, R. Geiger, and B. R. Cullen. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66:1-10 (1988).
18. Kieny, M. P., R. Lathe, and J. P. Lecocq. New versatile cloning and sequencing vectors based on bacteriophage M13. Gene 26:91-99 (1983).
19. Subramani, S., R. C. Mulligan, and P. Berg. Expression of the mouse dihydrofolate reductase complementary deoxyribonucleic acid in simian virus40 vectors. Mol. Cell. Biol. 1:854-864 (1981).
20. Nedspasv, S. A., A. N. Shakhov, R. L. Turetskaya, V A. Mett, M. M. Azizov, G. P. Georgiev, V. G. Korobko, V. N. Dobrynin, S. A. Filippov, N. S. Bystrov, L. N. Boldyreva, S. A. Chuvpilo, A. M. Chumakov, L. N. Shingarova, and Y. A. Ovchinnikov. Tandem arrangement of genes coding for tumor necrosis factor (TNF-α) and lymphotoxin (TNF-β) in the human genome. Cold Spring Harb. Symp. Quant. Biol. 51:611-624 (1986).
21. McKnight, S. L., and R. Kingsbury. Transcriptional control signals of a eukaryotic protein-coding gene. Science (Washington D. C.) 217:316-324 (1982).
22. Luckow, B., and G. Schüz. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acid Res. 13:5490 (1987).
23. Gendelman, H. E., W. Phelps, L. Feigenbaum, J. M. Ostrove, A. Adachi, P. M. Howley, G. Khoury, H. S. Ginsberg, and M. A. Martin. Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc. Natl. Acad. Sci. USA 83:9759-9763 (1986).
24. Popo, H. B., H. Potten, C. N. Adra, K Jardine, G. Mullhofer, and M. W. McBurney. Polymorphisms in the coding and noncoding regions of murine Pgk-1 alleles. Biochem. Genet. 28:299-308 (1990).
25. Sambrook, J., E. F. Fritsch, and T. Maniatis. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989).
26. Schaap, A. P., H. Akhavan, and L. J. Homano. Chemiluminescent substrates for alkaline phosphatase: application to ultrasensitive enzyme-linked immunoassays and DNA probes. Clin. Chem. 35:1863-1864 (1989).
27. Schreiber, E., P. Matthias, M. M. Muller, and W. Scaffner. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:6419 (1989).
28. Nabel, G., and D. Baltimore. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (Lond.) 326:711-713 (1987).
29. Toledano, M. B., and W. J. Leonard. Modulation of transcription factor NFκB binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. USA 88:4328-4332 (1991).
30. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63 (1983).
31. Barré-Sinoussi, T., J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axeler-Blin, F. Vézinet-Brun, C. Rouzioux, W. Rozenbaum, and L. Montagnier. Isolation of a T-lymphocytropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (Washington D. C.) 220:868-871 (1983).
32. Traenckner, E. B.-M., S. Wilk, and P. A. Baeuerle. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J. 13:5433-5441 (1994).
33. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science (Washington D. C.) 267:1485-1488 (1995).
34. Traenckner, E. B.-M., H. L. Pahl, T. Henkel, K. N. Schmidt, S. Wilk, and P. A. Baeuerle. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14:2876-2883 (1995).
35. Whiteside, S. T., M. K. Ernst, O. LeBail, C. Laurent-Winter, N. Rice, and A. Israël. N- and C-terminal sequences control degradation of MAD3/IκB-α in response to inducers of NF-κB activity. Mol. Cell. Biol. 15:5539-5345 (1995).
36. Schreck, R., and P. A. Baeuerle. A role for oxygen radicals as second messengers. Trends Cell. Biol. 1:39-42 (1991).
37. Schulze-Osthoff, K., M. Los, and P. A. Baeuerle. Redox signalling by transcription factors NF-κB and AP-1 in lymphocytes. Biochem. Pharm. 50:735-741 (1995).
38. Leitman, D. C., R. C. J. Ribeiro, E. R. Mackow, J. D. Baxter, and B. L. West. Identification of a tumor necrosis factor-responsive element in the tumor necrosis factor a gene. J. Biol. Chem. 266:9343-9346 (1991).
39. Pope, R. M., A. Leutz, and S. A. Ness. C/EBPβ regulation of the tumor necrosis factor a gene. J. Clin. Invest. 94:1449-1455 (1994).
40. Krämer, B., K. Wiegmann, and M. Krönke. Regulation of the human TNF promoter by transcription factor Ets. J. Biol. Chem. 270:6577-6583 (1995).
41. Ziegler-Heitbrock, H. W. L., T. Stersdorf, J. Liese, B. Belohradsky, C. Weber, A. Wedel, R. Schreck, P. A. Báuerle, and M. Strübel. Pyrrolidine dithiocarbamate inhibits NF-κB mobilization and TNF production in human monocytes J. Immunol. 151:6986-6993 (1993).
42. Goldfeld, A. E., P. G. McCaffrey, J. L. Strominger, and A. Rao. Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor α gene promoter. J. Exp. Med. 178:1365-1379 (1993).
43. Nicolson, J. K., G. D. Cross, C. S. Callaway, and J. S. McDougal. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). J. Immunol. 137: 323-329 (1986).
44. Pomerantz, R. J., M. B. Feinberg, D. Trono, and D. Baltimore. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. J. Exp. Med. 172:253-261 (1990).
45. Chen, Z., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. Signal-induced site-specific phosphorylatlon targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9:1586-1597 (1995).
46. Miyamoto, S., M. Maki, M. J. Schmitt, M. Hatanaka, and J. M. Verma. Tumor necrosis factor α-induced phosphorylation of IκBα is a signal for its degradation but not dissociation from NF-κB. Proc. Natl. Acad. Sci. USA 91:12740-12744 (1994).
47. Finco T. S., A. A. Beg, and A. S. Baldwin, Jr. Inducible phosphorylation of is IκB-α is not sufficient for its dissociation from NF-κB and is inhibited by proteasome inhibitors. Proc. Natl. Acad. Sci. USA 91: 11884-11888 (1994).
48. Lin, Y. C., K. Brown, and U. Siebenlist. Activation of NF-κB requires proteolysis of the inhibitor IκB-α: signal-induced phosphorylation of IκB-α: alone does not release active NF-κB. Proc. Natl. Acad. Sci. USA 92:652-556 (1995).